Risk Score Developed for RA-Linked Interstitial Lung Disease
A score has been developed to stratify the risk for subclinical rheumatoid arthritis-associated interstitial lung disease (RA-ILD).
Interstitial Lung Disease
Pulmonary Ultrasonography Detects Interstitial Lung Disease in Rheumatoid Arthritis
Researchers investigated the potential role in ultrasonography in the detection of interstitial lung disease (ILD) in patients with rheumatoid arthritis (RA).
Effect of Interstitial Lung Disease Subtypes on COVID-19 Mortality
How does the COVID-19 mortality rate vary among patients with different subtypes of interstitial lung disease?
Factors Linked to Poor Prognosis of RA-Associated Interstitial Lung Disease Determined
Researchers assessed the effect of clinical characteristics and treatment options on the prognosis of patients with rheumatoid arthritis-associated interstitial lung disease.
Long-COVID Lung Disease: Researchers Characterize 3 Phenotypes
Can long-COVID lung diseases be better understood and classified via analysis of abnormalities seen on transbronchial lung cryobiopsies?
Progressive Fibrosing Interstitial Lung Disease: Prevalence and Characteristics
What characterizes the progressive fibrosing ILD phenotype, and what baseline factors associated with this phenotype may help guide clinical decision making?
Sex and Gender in Asthma, COPD, OSA, ILD, and Lung Cancer
A “state-of-the-art” review of sex and gender differences in asthma, COPD, OSA, and ILD, points to the need for more research on these diseases as they relate to women/females.
Interstitial Lung Disease in Patients with Primary Sjögren’s Syndrome
Researchers in China identified risk factors and initial symptoms for interstitial lung disease in primary Sjögren’s Syndrome and estimated the prevalence of ILD-pSS.
Parent Satisfaction, HRQoL, and Genomic Testing for Children with chILD
What kind of additional support is needed for families of children undergoing genomic testing for interstitial or diffuse lung disease?
Nintedanib Slows Decline in FVC in Autoimmune Disease-Linked ILD
Nintedanib slows the rate of decline in FVC compared with placebo for patients with interstitial lung diseases ILDs.
- Loading...
Loading...
Next post in Restrictive Lung Disease
Loading... 
Loading...